A detailed history of Rda Financial Network transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Rda Financial Network holds 2,282 shares of VRTX stock, worth $1.08 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,282
Previous 1,713 33.22%
Holding current value
$1.08 Million
Previous $697,000 36.73%
% of portfolio
0.33%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$407.69 - $446.08 $231,975 - $253,819
569 Added 33.22%
2,282 $953,000
Q4 2023

Jan 12, 2024

BUY
$343.0 - $410.68 $115,934 - $138,809
338 Added 24.58%
1,713 $697,000
Q3 2023

Oct 18, 2023

BUY
$338.18 - $362.46 $113,628 - $121,786
336 Added 32.34%
1,375 $478,000
Q2 2023

Jul 13, 2023

BUY
$314.42 - $351.91 $53,451 - $59,824
170 Added 19.56%
1,039 $365,000
Q1 2023

Apr 12, 2023

BUY
$283.23 - $323.1 $246,126 - $280,773
869 New
869 $273,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rda Financial Network Portfolio

Follow Rda Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rda Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Rda Financial Network with notifications on news.